Post Deleted
…………………….. …………………….. …………………….. …………………….. …………………….. …………………….. …………………….. …………………….. …………………….. …………………….. …………………….. ……………………..
Trending Content
| +72 | BBs With The Hottest Girls | 34 | 17h | |
| +43 | Equinox Membership worth it? | 39 | 1d | |
| +38 | I want a puppy - talk me out of it | 25 | 3d | |
| +23 | PIF and Riyadh | 7 | 2d | |
| +19 | RENT MEGATHREAD: How much do you pay for rent? | 23 | 2d | |
| +19 | Am I a possible victim of identity theft (United Kingdom)??? I'm PARANOID | 8 | 6d | |
| +18 | IB Analyst Creed (must repeat every morning) | 5 | 3d | |
| +18 | Help: Three statement modeling for non-profits | 2 | 1d | |
| +18 | What was the most critical thinking you have done in a role? | 8 | 21h | |
| +14 | Advice to get into Whiskey | 16 | 1d |
Career Resources
Not to hijack post, but has anyone watched and recommend Shkreli's yt analysis of biotech/pharma companies?
Gotta be honest DCFs in healthcare are used very infrequently. Why would you use a perpetuity formula when the cash flows will significantly change once the patent expires and the market floods with generics?
What method is typically used to value companies in healthcare?
Why are you looking for FV and not PV?
Alias optio quod ut totam aut eum ut non. Sit tempora id animi aut ipsam tempora. Dolor consequatur est exercitationem optio soluta. Quibusdam accusamus et et nihil veritatis autem. Dolores quia id quia doloremque aut nihil minus.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...